Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69093 |
Epirubicin
IMI-28,表柔比星,4-epi DX,4'-Epidoxorubicin,IMI 28,4-epidoxorubicin,epi DX,4-epiadriamycin |
||
Epirubicin (4'-Epidoxorubicin) 是阿霉素的半合成的 L-阿拉伯糖衍生物,能够抑制 Topoisomerase,起到抗肿瘤的作用。Epirubicin 抑制 DNA 和 RNA 合成。Epirubicin 是一种 Forkhead box 蛋白 p3 (Foxp3) 抑制剂,可抑制调节性 T 细胞活性。 | |||
T0125 |
Epirubicin hydrochloride
Pharmorubicin,4'-epidoxorubicin HCl,Epirubicin HCl,盐酸表柔比星,4'-Epidoxorubicin hydrochloride |
Apoptosis; DNA/RNA Synthesis; Topoisomerase | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Epirubicin hydrochloride (Pharmorubicin) 是一种阿霉素的半合成 L-阿拉伯糖衍生物,是一种 Forkhead box 蛋白 p3 抑制剂,可抑制调节性 T 细胞活性。它抑制 DNA 和 RNA 合成,还能够抑制拓扑异构酶,起抗肿瘤作用。 | |||
T37068 |
NR-160
|
||
NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50= 0.03 μM).1It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 μM, respectively). NR-160 is cytotoxic against a panel of seven cancer cell lines (IC50s = 22.5-51.8 μM). It enhances cytotoxicity induced by bortezomib in HL-60 cells, as well as cytotoxicity induced by epirubicin or daunorubicin in CCRF-HSB-2 T cell acute lymphoblastic leukemia cells. |